Safety and Efficacy Results of Phase I/II SCOOP Trial in mCRC
Akihito Kawazoe, MD, discussed the safety and efficacy results of the phase I/II SCOOP trial of napabucasin plus pembrolizumab for treatment of patients with metastatic colorectal cancer.